Compounds > bendamustine hydrochloride
Page last updated: 2024-08-25

bendamustine hydrochloride and Central Nervous System Neoplasms

bendamustine hydrochloride has been researched along with Central Nervous System Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Aldrees, S; Jeeva-Patel, T; Margolin, E1
Martin, P1
Ahn, JS; Choi, HY; Jung, SH; Kim, HJ; Kim, T; Lee, HS; Lee, JJ; Yang, DH; Yoo, HD1
Chamberlain, MC1
Arbasino, C; Arcaini, L; Bonfichi, M; Cazzola, M; Da Vià, M; Delmonte, M; Gotti, M; Marchioni, E; Picchiecchio, A; Sciarra, R; Varettoni, M1
Chan, M; Detroye, A; Ellis, T; Johnson, A; Lesser, GJ; McMullen, K; Mott, R; Renfrow, JJ; Tatter, S1

Reviews

1 review(s) available for bendamustine hydrochloride and Central Nervous System Neoplasms

ArticleYear
Optimizing therapy for mantle cell lymphoma.
    Hematology. American Society of Hematology. Education Program, 2017, 12-08, Volume: 2017, Issue:1

    Topics: Bendamustine Hydrochloride; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma, Mantle-Cell; Rituximab

2017

Other Studies

5 other study(ies) available for bendamustine hydrochloride and Central Nervous System Neoplasms

ArticleYear
Bilateral Infiltrative Optic Neuropathy of Systemic Mantle Cell Lymphoma.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Central Nervous System Neoplasms; Cytarabine; Fundus Oculi; Humans; Lymphoma, Mantle-Cell; Male; Methotrexate; Optic Nerve; Optic Nerve Diseases; Rituximab

2020
Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL).
    BMC cancer, 2018, Jul-09, Volume: 18, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Central Nervous System Neoplasms; Female; Humans; Lymphoma; Male; Middle Aged; Pilot Projects; Salvage Therapy

2018
Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series.
    Journal of neuro-oncology, 2014, Volume: 118, Issue:1

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Central Nervous System Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Retrospective Studies; Salvage Therapy; Treatment Outcome

2014
Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.
    American journal of hematology, 2015, Volume: 90, Issue:8

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Bone Marrow; Central Nervous System Neoplasms; Humans; Immunologic Factors; Male; Middle Aged; Nitrogen Mustard Compounds; Remission Induction; Rituximab; Treatment Outcome; Waldenstrom Macroglobulinemia

2015
Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report.
    Journal of neuro-oncology, 2012, Volume: 107, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Central Nervous System Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds

2012